PH PHARMANET EU

Company Description

Having established itself as a major Manufacturer and Supplier of HYALURONIC ACID CROSS-LINKED around the world, PH PHARMANET EU had been earning Approx 0.5 Billion US Dollar annually since its inception 6 Years ago. With an export rate of about US$50 Million - US$100 Million earned yearly, the estimated market share of PH PHARMANET EU is Australia,Canada,India,South Korea,United Kingdom,United States. Having said all of this, European and Oceanic market is still yet to be discovered by the industry; however, this graph may change ahead in the future. Originating from Bogota, , Colombia, PH PHARMANET EU started off with an initial investment of US$5 Million - US$10 Million in 2014. A Corporation Limited Liability Company with Own Lisence; the company plans to expand its roots in different countries in the coming years. For any further details on Hyaluronic Acid Cosmetic Grade products, feel free to contact Claudio Martin on provided details.